Risk of Colorectal Cancer and Cancer Related Mortality After Detection of Low-risk or High-risk Adenomas, Compared With No Adenoma, at Index Colonoscopy: A Systematic Review and Meta-analysis
- PMID: 33524401
- DOI: 10.1053/j.gastro.2021.01.214
Risk of Colorectal Cancer and Cancer Related Mortality After Detection of Low-risk or High-risk Adenomas, Compared With No Adenoma, at Index Colonoscopy: A Systematic Review and Meta-analysis
Erratum in
-
Correction.Gastroenterology. 2022 Aug;163(2):536. doi: 10.1053/j.gastro.2022.06.016. Epub 2022 Jun 11. Gastroenterology. 2022. PMID: 35697098 No abstract available.
Abstract
Background & aims: The risk of metachronous colorectal cancer (CRC) among patients with no adenomas, low-risk adenomas (LRAs), or high-risk adenomas (HRAs), detected at index colonoscopy, is unclear. We performed a systematic review and meta-analysis to compare incidence rates of metachronous CRC and CRC-related mortality after a baseline colonoscopy for each group.
Methods: We searched the PubMed, Embase, Google Scholar, and Cochrane databases for studies that reported the incidence of CRC and adenoma characteristics after colonoscopy. The primary outcome was odds of metachronous CRC and CRC-related mortality per 10,000 person-years of follow-up after baseline colonoscopy for all the groups.
Results: Our final analysis included 12 studies with 510,019 patients (mean age, 59.2 ± 2.6 years; 55% male; mean duration of follow up, 8.5 ± 3.3 years). The incidence of CRC per 10,000 person-years was marginally higher for patients with LRAs compared to those with no adenomas (4.5 vs 3.4; odds ratio [OR], 1.26; 95% CI, 1.06-1.51; I2=0), but significantly higher for patients with HRAs compared to those with no adenoma ( 13.8 vs 3.4; odds ratio [OR], 2.92; 95% CI, 2.31-3.69; I2=0 ) and patients with HRAs compared to LRAs (13.81 vs 4.5; OR, 2.35; 95% CI, 1.72-3.20; I2=55%). However, the CRC-related mortality per 10,000 person-years did not differ significantly for patients with LRAs compared to no adenomas (OR, 1.15; 95% CI, 0.76-1.74; I2=0) but was significantly higher in persons with HRAs compared with LRAs (OR, 2.48; 95% CI, 1.30-4.75; I2=38%) and no adenomas (OR, 2.69; 95% CI, 1.87-3.87; I2=0).
Conclusions: The results of this systematic review and meta-analysis demonstrate that the risk of metachronous CRC and mortality is significantly higher for patients with HRAs, but this risk is very low in patients with LRAs, comparable to patients with no adenomas. Follow-up of patients with LRAs detected at index colonoscopy should be the same as for persons with no adenomas.
Keywords: Colon Cancer; Polyp; Risk of Death; Tumor Development.
Copyright © 2021 AGA Institute. All rights reserved.
Similar articles
-
Incidence and Mortality of Post-Polypectomy Colorectal Cancer in Patients with Low-Risk Adenomas: A Systematic Review and Meta-Analysis of Observational Studies.Dig Dis. 2023;41(2):206-216. doi: 10.1159/000524138. Epub 2022 Mar 29. Dig Dis. 2023. PMID: 35350026
-
Risk of Advanced Adenoma, Colorectal Cancer, and Colorectal Cancer Mortality in People With Low-Risk Adenomas at Baseline Colonoscopy: A Systematic Review and Meta-Analysis.Am J Gastroenterol. 2017 Dec;112(12):1790-1801. doi: 10.1038/ajg.2017.360. Epub 2017 Oct 31. Am J Gastroenterol. 2017. PMID: 29087393 Review.
-
Low Colorectal Cancer Risk After Resection of High-Risk Pedunculated Polyps.Clin Gastroenterol Hepatol. 2024 Jul;22(7):1518-1527.e7. doi: 10.1016/j.cgh.2024.01.027. Epub 2024 Feb 5. Clin Gastroenterol Hepatol. 2024. PMID: 38325601
-
Risk Factors for Metachronous Colorectal Cancer or Advanced Adenomas After Endoscopic Resection of High-risk Adenomas.Clin Gastroenterol Hepatol. 2023 Mar;21(3):630-643. doi: 10.1016/j.cgh.2022.12.005. Epub 2022 Dec 20. Clin Gastroenterol Hepatol. 2023. PMID: 36549471 Review.
-
Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on Outcome.Gastroenterology. 2017 Jun;152(8):1933-1943.e5. doi: 10.1053/j.gastro.2017.02.010. Epub 2017 Feb 20. Gastroenterology. 2017. PMID: 28219690 Free PMC article. Clinical Trial.
Cited by
-
Potential Impact of Extending Surveillance Intervals for Patients With 1-2 Low-Risk Adenomas.Gastro Hep Adv. 2022 Nov 29;2(3):298-300. doi: 10.1016/j.gastha.2022.11.011. eCollection 2023. Gastro Hep Adv. 2022. PMID: 39132662 Free PMC article. Review. No abstract available.
-
Adherence to Recommendations for Repeat Surveillance After Publication of New Postpolypectomy Guidelines.Gastro Hep Adv. 2022 Jul 31;2(1):132-143. doi: 10.1016/j.gastha.2022.07.014. eCollection 2023. Gastro Hep Adv. 2022. PMID: 39130145 Free PMC article.
-
Correlations of pathomorphological parameters between lesions at the invasive front and lymph node metastases in colorectal cancer: a retrospective clinical study.J Egypt Natl Canc Inst. 2024 Jul 1;36(1):23. doi: 10.1186/s43046-024-00228-0. J Egypt Natl Canc Inst. 2024. PMID: 38945978
-
AGA Clinical Practice Update on Risk Stratification for Colorectal Cancer Screening and Post-Polypectomy Surveillance: Expert Review.Gastroenterology. 2023 Nov;165(5):1280-1291. doi: 10.1053/j.gastro.2023.06.033. Epub 2023 Sep 21. Gastroenterology. 2023. PMID: 37737817 Free PMC article.
-
The impact on clinical outcomes and healthcare resources from discontinuing colonoscopy surveillance subsequent to low-risk adenoma removal: A simulation study using the OncoSim-Colorectal model.J Med Screen. 2024 Jun;31(2):78-84. doi: 10.1177/09691413231202877. Epub 2023 Sep 20. J Med Screen. 2024. PMID: 37728194 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
